Profile data is unavailable for this security.
About the company
Amplifon SpA is an Italy-based company active in the hearing care retail market. The Company provides personalized solutions and customer care to hearing-impaired people. It offers a wide range of services from diagnosing hearing difficulties, to fitting, servicing and maintaining hearing aids. The Company is organized in three geographical operating segments: Europe, Middle East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Ireland, Spain, Portugal, Switzerland, Belgium, Luxemburg, Hungary, Egypt, Turkey, Poland and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama and Mexico) and Asia-Pacific (Australia, New Zealand, India and China).
- Revenue in EUR (TTM)2.29bn
- Net income in EUR160.70m
- Incorporated--
- Employees14.38k
- LocationAmplifon SpAVia Ripamonti 133MILANO 20141ItalyITA
- Phone+39 2574721
- Fax+39 257300033
- Websitehttps://www.amplifon.com/
More ▼
Mergers & acquisitions
| Acquired company | AMP:MIL since announced | Transaction value |
|---|---|---|
| Miracle-Ear Centers of Arkansas LLC | 3.21% | -- |
| Las Davis Enterprises Inc | 3.21% | -- |
| Hearing Pro Inc | 3.21% | -- |
| Audical SRL | 2.75% | -- |
| Living Sounds Hearing Centre | 7.15% | -- |
Data delayed at least 15 minutes, as of Jul 22 2024 16:35 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gerresheimer AG | 2.00bn | 115.11m | 3.38bn | 11.91k | 29.40 | 2.29 | 11.04 | 1.69 | 3.33 | 3.33 | 57.96 | 42.82 | 0.5838 | 4.00 | 6.68 | 171,666.00 | 3.42 | 3.31 | 4.63 | 4.75 | 29.35 | 29.72 | 5.86 | 5.94 | 0.5053 | 4.59 | 0.4425 | 42.68 | 9.54 | 7.79 | 20.81 | 9.00 | 23.42 | 1.68 |
| Sectra AB | 148.46m | 36.87m | 3.69bn | 1.20k | 106.41 | 29.04 | 81.35 | 24.83 | 2.22 | 2.22 | 8.95 | 8.15 | 0.5801 | 24.87 | 1.30 | 1,432,758.00 | 14.41 | 15.75 | 28.61 | 29.52 | 47.24 | 64.95 | 24.83 | 19.59 | 1.56 | -- | 0.0199 | -- | 26.84 | 4.06 | 14.25 | 16.58 | 48.37 | -- |
| Ambu A/S | 680.38m | 49.20m | 4.26bn | 4.75k | 97.87 | 6.42 | 43.22 | 6.26 | 1.38 | 1.38 | 19.09 | 21.05 | 0.7251 | 2.13 | 7.17 | 1,099,437.00 | 5.24 | 3.81 | 5.99 | 4.62 | 57.91 | 59.37 | 7.23 | 5.43 | 1.49 | 16.93 | 0.101 | 22.89 | 7.45 | 12.88 | 80.65 | -13.00 | 6.67 | -- |
| Getinge AB | 2.87bn | 222.30m | 4.53bn | 11.89k | 21.86 | 1.79 | 11.64 | 1.58 | 9.48 | 9.48 | 122.36 | 115.57 | 0.6168 | 2.48 | 7.04 | 2,839,084.00 | 4.81 | 5.31 | 6.35 | 6.98 | 46.27 | 47.83 | 7.79 | 8.69 | 0.6455 | 8.99 | 0.2136 | 37.87 | 12.49 | 5.66 | -3.17 | -- | -0.3944 | 34.49 |
| SCHOTT Pharma AG & Co KgaA | 916.32m | 134.63m | 4.98bn | 4.65k | 37.13 | 6.85 | 25.82 | 5.43 | 0.8899 | 0.8899 | 6.05 | 4.82 | -- | -- | -- | 197,228.20 | -- | -- | -- | -- | 33.96 | -- | 14.73 | -- | 1.00 | -- | 0.1011 | -- | 9.43 | -- | 21.11 | -- | -- | -- |
| Ypsomed Holding AG | 566.96m | 81.01m | 5.50bn | 2.30k | 67.84 | 8.61 | 34.68 | 9.69 | 5.74 | 5.74 | 40.18 | 45.26 | 0.5587 | 5.40 | 4.96 | 238,875.00 | 7.98 | 4.41 | 12.40 | 6.81 | 34.47 | 27.26 | 14.29 | 7.38 | 0.5967 | 20.89 | 0.293 | 20.50 | 10.25 | 3.86 | 52.83 | 5.44 | 8.64 | 29.46 |
| Carl Zeiss Meditec AG | 2.06bn | 261.22m | 5.61bn | 4.95k | 21.41 | 2.68 | -- | 2.72 | 2.93 | 2.93 | 23.12 | 23.41 | 0.7296 | 1.81 | 5.57 | 427,523.50 | 9.27 | 9.56 | 11.33 | 11.72 | 56.32 | 57.84 | 12.70 | 13.15 | 2.41 | -- | 0.1018 | 34.47 | 9.80 | 10.28 | -1.20 | 18.09 | 26.79 | 14.87 |
| DiaSorin SpA | -100.00bn | -100.00bn | 5.70bn | 3.23k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.30 | -- | 11.50 | -- | 66.70 | -- | 21.25 | -- | -- | -- | 24.71 | -15.64 | 11.40 | -33.65 | 0.2167 | 16.49 | -- |
| ConvaTec Group PLC | 1.97bn | 119.79m | 6.14bn | 10.13k | 51.34 | 3.95 | 19.35 | 3.12 | 0.0491 | 0.0491 | 0.8079 | 0.6392 | 0.5865 | 2.57 | 6.14 | 163,720.50 | 3.57 | 2.36 | 4.18 | 2.73 | 56.04 | 55.03 | 6.08 | 4.34 | 0.8835 | 2.65 | 0.4367 | 127.29 | 3.37 | 3.18 | 107.15 | -6.93 | 12.37 | 31.41 |
| Amplifon SpA | 2.29bn | 160.70m | 6.74bn | 14.38k | 41.71 | 5.92 | 15.44 | 2.94 | 0.7137 | 0.7137 | 10.16 | 5.03 | 0.6183 | 20.30 | 10.56 | 159,464.60 | 4.34 | 4.31 | 6.35 | 5.81 | 23.78 | 59.01 | 7.03 | 7.28 | 0.4667 | 5.98 | 0.5814 | 34.26 | 6.65 | 10.66 | -12.21 | 9.08 | 12.68 | 15.68 |
| Demant A/S | 3.01bn | 342.13m | 7.68bn | 21.62k | 22.65 | 6.17 | -- | 2.55 | 11.44 | 8.05 | 100.58 | 41.97 | 0.7431 | 2.05 | 5.88 | 1,037,923.00 | 8.46 | 8.27 | 12.20 | 13.23 | 73.72 | 74.14 | 11.38 | 11.34 | 0.9529 | 5.98 | 0.6075 | 0.00 | 13.89 | 10.00 | 12.23 | 6.96 | 8.80 | -- |
Data as of Jul 22 2024. Currency figures normalised to Amplifon SpA's reporting currency: Euro EUR
13.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Comgest SAas of 29 Mar 2024 | 5.44m | 2.40% |
| Capital Research & Management Co. (World Investors)as of 30 Jun 2024 | 4.99m | 2.20% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 4.52m | 2.00% |
| Allianz Global Investors GmbHas of 30 Apr 2024 | 2.86m | 1.27% |
| T. Rowe Price International Ltd.as of 30 Jun 2024 | 2.37m | 1.05% |
| BlackRock Fund Advisorsas of 04 Jul 2024 | 2.30m | 1.02% |
| Norges Bank Investment Managementas of 02 May 2024 | 2.06m | 0.91% |
| Cr�dit Mutuel Asset Management SAas of 29 Dec 2023 | 2.03m | 0.90% |
| Amundi Asset Management SA (Investment Management)as of 03 Jul 2024 | 1.73m | 0.76% |
| DNCA Finance SAas of 29 Dec 2023 | 1.57m | 0.69% |
More ▼
Data from 31 Dec 2023 - 17 Jul 2024Source: FactSet Research Systems Inc.
